264 related articles for article (PubMed ID: 27325104)
21. Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma.
Li H; Kaminski MS; Li Y; Yildiz M; Ouillette P; Jones S; Fox H; Jacobi K; Saiya-Cork K; Bixby D; Lebovic D; Roulston D; Shedden K; Sabel M; Marentette L; Cimmino V; Chang AE; Malek SN
Blood; 2014 Mar; 123(10):1487-98. PubMed ID: 24435047
[TBL] [Abstract][Full Text] [Related]
22. Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas.
Martin-Guerrero I; Salaverria I; Burkhardt B; Szczepanowski M; Baudis M; Bens S; de Leval L; Garcia-Orad A; Horn H; Lisfeld J; Pellissery S; Klapper W; Oschlies I; Siebert R
Haematologica; 2013 Aug; 98(8):1237-41. PubMed ID: 23445872
[TBL] [Abstract][Full Text] [Related]
23. CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma.
Xian RR; Xie Y; Haley LM; Yonescu R; Pallavajjala A; Pittaluga S; Jaffe ES; Duffield AS; McCall CM; Gheith SMF; Gocke CD
Blood Cancer J; 2020 Jun; 10(6):69. PubMed ID: 32555149
[TBL] [Abstract][Full Text] [Related]
24. EZH2 mutations are frequent and represent an early event in follicular lymphoma.
Bödör C; Grossmann V; Popov N; Okosun J; O'Riain C; Tan K; Marzec J; Araf S; Wang J; Lee AM; Clear A; Montoto S; Matthews J; Iqbal S; Rajnai H; Rosenwald A; Ott G; Campo E; Rimsza LM; Smeland EB; Chan WC; Braziel RM; Staudt LM; Wright G; Lister TA; Elemento O; Hills R; Gribben JG; Chelala C; Matolcsy A; Kohlmann A; Haferlach T; Gascoyne RD; Fitzgibbon J
Blood; 2013 Oct; 122(18):3165-8. PubMed ID: 24052547
[TBL] [Abstract][Full Text] [Related]
25. Genetics of follicular lymphoma transformation.
Pasqualucci L; Khiabanian H; Fangazio M; Vasishtha M; Messina M; Holmes AB; Ouillette P; Trifonov V; Rossi D; Tabbò F; Ponzoni M; Chadburn A; Murty VV; Bhagat G; Gaidano G; Inghirami G; Malek SN; Rabadan R; Dalla-Favera R
Cell Rep; 2014 Jan; 6(1):130-40. PubMed ID: 24388756
[TBL] [Abstract][Full Text] [Related]
26. Recurrent mutations in genes involved in nuclear factor-κB signalling in nodal marginal zone lymphoma-diagnostic and therapeutic implications.
van den Brand M; Rijntjes J; Hebeda KM; Menting L; Bregitha CV; Stevens WB; van der Velden WJ; Tops BB; van Krieken JH; Groenen PJ
Histopathology; 2017 Jan; 70(2):174-184. PubMed ID: 27297871
[TBL] [Abstract][Full Text] [Related]
27. Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.
Laurent C; Nicolae A; Laurent C; Le Bras F; Haioun C; Fataccioli V; Amara N; Adélaïde J; Guille A; Schiano JM; Tesson B; Traverse-Glehen A; Chenard MP; Mescam L; Moreau A; Chassagne-Clement C; Somja J; Escudié F; André M; Martin N; Lacroix L; Lemonnier F; Hamy AS; Reyal F; Bannier M; Oberic L; Prade N; Frénois FX; Beldi-Ferchiou A; Delfau-Larue MH; Bouabdallah R; Birnbaum D; Brousset P; Xerri L; Gaulard P
Blood; 2020 Jan; 135(5):360-370. PubMed ID: 31774495
[TBL] [Abstract][Full Text] [Related]
28. Application of circulating tumour DNA in terms of prognosis prediction in Chinese follicular lymphoma patients.
Zhao M; Li Q; Yang J; Zhang M; Liu X; Zhang H; Huang Y; Li J; Bao J; Wang J; Du J; Guan T; Su L
Front Genet; 2023; 14():1066808. PubMed ID: 37152994
[No Abstract] [Full Text] [Related]
29. Molecular subclusters of follicular lymphoma: a report from the United Kingdom's Haematological Malignancy Research Network.
Crouch S; Painter D; Barrans SL; Roman E; Beer PA; Cooke SL; Glover P; Van Hoppe SJL; Webster N; Lacy SE; Ruiz C; Campbell PJ; Hodson DJ; Patmore R; Burton C; Smith A; Tooze RM
Blood Adv; 2022 Nov; 6(21):5716-5731. PubMed ID: 35363872
[TBL] [Abstract][Full Text] [Related]
30. Pathogenesis of follicular lymphoma.
Lackraj T; Goswami R; Kridel R
Best Pract Res Clin Haematol; 2018 Mar; 31(1):2-14. PubMed ID: 29452662
[TBL] [Abstract][Full Text] [Related]
31. Clinical, pathological and genetic features of follicular lymphoma grade 3A: a joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHL.
Koch K; Hoster E; Ziepert M; Unterhalt M; Ott G; Rosenwald A; Hansmann ML; Bernd W; Stein H; Pöschel V; Dreyling M; Trümper L; Löffler M; Schmitz N; Hiddemann W; Pfreundschuh M; Klapper W
Ann Oncol; 2016 Jul; 27(7):1323-9. PubMed ID: 27117536
[TBL] [Abstract][Full Text] [Related]
32. Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV.
Los-de Vries GT; Stevens WBC; van Dijk E; Langois-Jacques C; Clear AJ; Stathi P; Roemer MGM; Mendeville M; Hijmering NJ; Sander B; Rosenwald A; Calaminici M; Hoster E; Hiddemann W; Gaulard P; Salles G; Horn H; Klapper W; Xerri L; Burton C; Tooze RM; Smith AG; Buske C; Scott DW; Natkunam Y; Advani R; Sehn LH; Raemaekers J; Gribben J; Kimby E; Kersten MJ; Maucort-Boulch D; Ylstra B; de Jong D
Blood Adv; 2022 Sep; 6(18):5482-5493. PubMed ID: 35816682
[TBL] [Abstract][Full Text] [Related]
33. Recurrent mutations of NOTCH genes in follicular lymphoma identify a distinctive subset of tumours.
Karube K; Martínez D; Royo C; Navarro A; Pinyol M; Cazorla M; Castillo P; Valera A; Carrió A; Costa D; Colomer D; Rosenwald A; Ott G; Esteban D; Giné E; López-Guillermo A; Campo E
J Pathol; 2014 Nov; 234(3):423-30. PubMed ID: 25141821
[TBL] [Abstract][Full Text] [Related]
34. Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma.
Green MR; Gentles AJ; Nair RV; Irish JM; Kihira S; Liu CL; Kela I; Hopmans ES; Myklebust JH; Ji H; Plevritis SK; Levy R; Alizadeh AA
Blood; 2013 Feb; 121(9):1604-11. PubMed ID: 23297126
[TBL] [Abstract][Full Text] [Related]
35. A high definition picture of key genes and pathways mutated in pediatric follicular lymphoma.
Lovisa F; Binatti A; Coppe A; Primerano S; Carraro E; Pillon M; Pizzi M; Guzzardo V; Buffardi S; Porta F; Farruggia P; De Santis R; Bulian P; Basso G; Lazzari E; d'Amore ESG; Bortoluzzi S; Mussolin L
Haematologica; 2019 Sep; 104(9):e406-e409. PubMed ID: 30819919
[No Abstract] [Full Text] [Related]
36. Somatic mutation of the 5' noncoding region of the BCL-6 gene is associated with intraclonal diversity and clonal selection in histological transformation of follicular lymphoma.
Szereday Z; Csernus B; Nagy M; László T; Warnke RA; Matolcsy A
Am J Pathol; 2000 Mar; 156(3):1017-24. PubMed ID: 10702417
[TBL] [Abstract][Full Text] [Related]
37. Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia.
Quintanilla-Martinez L; Sander B; Chan JK; Xerri L; Ott G; Campo E; Swerdlow SH
Virchows Arch; 2016 Feb; 468(2):141-57. PubMed ID: 26416032
[TBL] [Abstract][Full Text] [Related]
38. The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy.
Egan C; Lack J; Skarshaug S; Pham TA; Abdullaev Z; Xi L; Pack S; Pittaluga S; Jaffe ES; Raffeld M
Mod Pathol; 2021 Feb; 34(2):336-347. PubMed ID: 32929178
[TBL] [Abstract][Full Text] [Related]
39. Tumor suppressors in follicular lymphoma.
Graham C; LeBrun DP
Leuk Lymphoma; 2015 Jul; 56(7):1981-8. PubMed ID: 25379618
[TBL] [Abstract][Full Text] [Related]
40. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
Burkhard R; Bhagat G; Cogliatti SB; Rossi D; Gaidano G; Pasqualucci L; Novak U
Hematol Oncol; 2015 Mar; 33(1):23-30. PubMed ID: 24496723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
